Albemarle — May 6, 2026 release

Other Corporate FY 2026E Capital expenditures $550 - $600 million Depreciation and amortization $660 - $680 million Adjusted effective tax rate (a) (50)% - 30% Corporate adjusted EBITDA (incl. FX, Ketjen equity income & PCS) ($20) - $20 million Interest and financing expenses $120 - $140 million Weighted-average common shares outstanding (diluted) (b) ~118 million (a)    Adjusted effective tax rate dependent on lithium market prices and geographic income mix (b)    Diluted weighted-average common shares outstanding amount assumes the net income attributable to common shareholders will be reduced by mandatory convertible preferred stock dividends. If the assumed conversion of preferred stock results in a more dilutive earnings per share, the diluted weighted-average common shares outstanding will reflect this conversion. Cash Flow and Capital Deployment Cash from operations of $346 million in the first three months of 2026 decreased $201 million compared to the prior-year period. First quarter 2025 cash from operations included a one-time $350 million customer prepayment. Capital expenditures of $99 million in the first three months of 2026 decreased by $84 million versus the prior-year period. Balance Sheet and Liquidity As of March 31, 2026, Albemarle had estimated liquidity of approximately $2.7 billion, including $1.1 billion of cash and cash equivalents, $1.5 billion available under our revolver and $87 million avail